Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
This study is currently recruiting participants.
Verified February 2013
by Eisai Inc.
Study NCT01127451 Information provided by Eisai Inc.
First Received on May 19, 2010. Last Updated on March 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage IIIC Melanoma
Stage IV Melanoma
Additional conditions recognized in this trial
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Nevi and Melanomas
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents
Sponsors listed in this trial
PharmaBio Development Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers